Two Sigma Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Two Sigma Securities's BIIB Position: Q1 2026 in Review
Two Sigma Securities reduced its Biogen (BIIB) stake by 75% in Q1 2026, selling an estimated $755K and leaving 1,335 shares worth $245K. The position accounts for 0.03% of the portfolio, ranked #923.
Two Sigma Securities first reported a position in BIIB in Q4 2015 and has held it in 23 quarters since. The position peaked at $2.49M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Two Sigma Securities held 1,335 shares of Biogen worth $245K as of Q1 2026.
- Two Sigma Securities sold 4,095 Biogen shares in Q1 2026, an estimated $755K.
- Biogen made up 0.03% of Two Sigma Securities's portfolio in Q1 2026, its #923 holding.
- Two Sigma Securities first reported a position in Biogen in Q4 2015 and has held it in 23 quarters since.
- Two Sigma Securities's Biogen position peaked at $2.49M in Q3 2018.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.